The interaction between HMGA2 and JAK2V617F as well as whether, in patients with JAK2-mutated MPN, HMGA2 overexpression has a specific role in the disease pathogenesis have yet to be clarified [115]. Here, JAK2 is linked to myeloproliferative disorder.